Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
about
Prodrug Strategies for PaclitaxelPlasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticlesDevelopment and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic CancerBionanotechnology and the future of glioma.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography.XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticlesImaging of VEGF receptor in a rat myocardial infarction model using PETGenome-free viral capsids as multivalent carriers for taxol delivery.Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.Integrin targeted delivery of chemotherapeuticsImaging and cancer: a review.Prodrugs for improving tumor targetability and efficiency.Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptidesEndosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel.Targeted imaging and therapy of brain cancer using theranostic nanoparticlesAdvancement and applications of peptide phage display technology in biomedical scienceThe Role of Molecular Imaging in Drug Delivery.Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imagingTargeting integrins for the control of tumour angiogenesis.Bicyclic Peptides as Next-Generation Therapeutics.Nanotechnology-based drug delivery systemsA cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy.Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancerIntracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization.Drug delivery with carbon nanotubes for in vivo cancer treatmentCell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.Integrin targeted drug and gene delivery.Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanomaMolecular imaging and targeted therapies.Peptide-mediated targeted drug delivery.Integrin targeted delivery of gene therapeuticsRecent advances in ligand targeted therapy.Tumour vasculature targeting agents in hybrid/conjugate drugs.Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.Oxadiazoles as privileged motifs for promising anticancer leads: recent advances and future prospects.The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application.
P2860
Q26745997-32CD741D-A1D3-4CD5-9DB9-5E1DBCDE1409Q27339171-801BD308-6C3F-4DC9-B93F-9FC27FE17FADQ28552050-9F08096C-35BC-4408-9A5D-6A8D33502A59Q30417964-BA28F7C3-38D7-4BDA-81CF-25C237F5563CQ33230098-E0B6F547-A503-4E7D-99A3-313A58DB1118Q33318187-F332684C-8F69-4138-8DFE-8D2C62E11411Q33774391-2211D2B9-EAD9-468C-B14E-54F09D686540Q33786497-554A07D4-1074-43F0-BBCA-787D93F2CEB3Q34057731-F85361B4-7372-46C1-B115-5FFCACDAC5CAQ34159304-8A2239D1-7795-4C7E-B10B-8D65911050CAQ34912725-0B9307FC-14FA-46C9-9E57-8533074578B7Q34977050-391D3F42-F6F3-4347-9CD2-5B6D7CF62CE9Q35095165-AB3CBA24-B8C3-45BB-8A79-F502DECAC91EQ35246152-F3E1B447-ADB8-45E9-92E3-7ED0E4CC1C9FQ35560114-FE7E85B5-861D-4056-AFCE-7355016EBCFCQ35792897-4B7EC13E-BBA2-47AD-BBCC-5D6C6A1846A3Q35898339-94FAC4C6-8BE1-42E6-A48F-C162F3197215Q36108266-82B12AFD-7D21-45B0-8A1D-3C806B52293DQ36177171-6C618362-E73D-4FDD-A41A-30E995776016Q36322066-C61A66F0-C66A-4BF6-9C0B-FA7EF6AA040AQ36394825-9E5D917B-6B92-4339-A710-D7FCE0235195Q36419770-AEE49BDD-329A-4DAB-B39B-4E820D5CF979Q36528120-F0C85515-FA23-436D-B9C4-84B5DCD26DD6Q36542204-0374C05D-CDCF-422C-9072-5A61B7CB36E1Q36546746-2F48E977-C0C3-4CF7-A1C9-CF3171B363E0Q36649655-5E13582A-25EF-41DC-B393-7D2D16F86FBCQ36723768-5F61F4E8-8CFE-4620-8498-88F79F1F3375Q36925878-10C2E13D-4060-4400-979E-DD18C4FB09ADQ37668316-7B5956C8-90B5-48DF-B87C-F97E29E1F571Q37679945-CAA616C6-6672-4CE5-949B-F67E63917995Q37702351-42C30993-9C51-410F-BC56-E3C1A456A01AQ37732704-BD4C6B3B-21F7-49EC-8715-7D52DC67E0E0Q37785045-1FC28A74-A991-4540-A6C8-A0DB1926A684Q37872613-F64EEA67-F0FF-457A-9C8B-02E70DAFFDE3Q37937611-E233CCB7-63DC-4226-A964-AB188F0F724CQ38094627-25DF6120-4EF6-402D-898A-90156093B30AQ38124818-70236319-0385-46C8-91BC-F05DB5BEC12DQ38165135-10423488-EEE2-4CC2-82E2-A05BD4EBD4DDQ38176391-C334BBBC-BB65-4A8C-A222-C7770894CDC3Q38691500-195624BE-C05F-47E4-87AC-27BD1D9F6ACF
P2860
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Synthesis and biological evalu ...... tegrin-targeted drug delivery.
@en
type
label
Synthesis and biological evalu ...... tegrin-targeted drug delivery.
@en
prefLabel
Synthesis and biological evalu ...... tegrin-targeted drug delivery.
@en
P2093
P356
P1476
Synthesis and biological evalu ...... tegrin-targeted drug delivery.
@en
P2093
Carmen Plasencia
Nouri Neamati
Xiaoyuan Chen
Yingping Hou
P304
P356
10.1021/JM049165Z
P407
P577
2005-02-01T00:00:00Z